A 28-year-old primigravida at 24 weeks of gestation is diagnosed with gestational diabetes mellitus on oral glucose tolerance test. She has no prior history of diabetes and is otherwise healthy. Diet and lifestyle modifications are initiated, but after 2 weeks of close monitoring, fasting blood glucose remains 135 mg/dL and postprandial glucose is 165 mg/dL. What is the drug of choice for pharmacological management in this patient?

## Drug of Choice for Gestational Diabetes Mellitus Requiring Pharmacotherapy **Key Point:** Insulin is the drug of choice (gold standard) for pharmacological management of gestational diabetes mellitus (GDM) when diet and lifestyle modifications fail, as per ACOG, WHO, and Indian (FOGSI/DIPSI) guidelines. ### Why Insulin is the Drug of Choice 1. **Does Not Cross the Placenta** - Insulin is a large polypeptide molecule and does not cross the placental barrier - Ensures no direct fetal exposure to the drug - This is the primary reason for its preferred status in pregnancy 2. **Established Safety and Efficacy** - Decades of safety data in pregnancy - Effective across the full spectrum of hyperglycemia severity - Can be titrated precisely to achieve glycemic targets - No teratogenic effects 3. **Guideline Endorsement** - ACOG (American College of Obstetricians and Gynecologists) recommends insulin as the preferred first-line pharmacological agent for GDM - WHO and most international bodies list insulin as the standard of care - Indian FOGSI guidelines also recommend insulin as first-line pharmacotherapy for GDM 4. **Specific Insulin Regimen in GDM** - Intermediate-acting insulin (NPH/Isophane) or basal-bolus regimens are commonly used - Insulin glargine (long-acting analog) is also used and is considered safe in pregnancy - Dose adjusted based on fasting and postprandial glucose monitoring ### Why Other Options Are Incorrect - **Metformin (A):** While metformin is used in some centers and is acceptable per certain guidelines (e.g., NICE UK), it crosses the placenta and is NOT universally recognized as the drug of choice for GDM in standard Indian/ACOG exam contexts. It is considered an alternative when insulin is refused or unavailable. - **Glyburide (C):** Crosses the placenta; associated with neonatal hypoglycemia and macrosomia; not recommended as first-line. - **Acarbose (D):** Limited efficacy data in GDM; not recommended as first-line pharmacotherapy. **High-Yield:** For NEET PG / INI-CET purposes, **Insulin** is the drug of choice for GDM requiring pharmacological treatment. Metformin may be used as an alternative oral agent but is not the standard first-line drug of choice per ACOG and Indian exam guidelines. **Clinical Pearl:** The question stem specifies that diet and lifestyle modifications have failed and glucose targets are not met — this is the classic scenario where insulin initiation is indicated as the drug of choice (Harrison's Principles of Internal Medicine, 21st ed.; Williams Obstetrics, 25th ed.). **Mnemonic:** **INSULIN in GDM** = **I**deal first-line, **N**o placental crossing, **S**afe in all trimesters, **U**niversally recommended, **L**arge molecule, **I**ndian guidelines approved, **N**o teratogenicity